National Comprehensive Cancer Network

NCCN Research & Business Resources

NCCN Oncology Research Program (ORP) Recent News

The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying investigators and initiating clinical trials at NCCN Member Institutions. The NCCN ORP draws on the expertise of investigators at 21 of the world’s leading cancer centers and establishes collaborations with pharmaceutical and biotechnology companies in order to advance therapeutic options for patients with cancer. To date, the NCCN ORP has provided almost $30 million in research funding to investigators at NCCN Member Institutions. Click on a press release below to learn more about the NCCN ORP.

• NCCN Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim to Investigate Afatinib in Solid Tumors (11/10/2011)
• NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline (10/11/2011)
• NCCN/BRAF Inhibitor GSK2118436 – Research Grant Opportunity (9/22/2011)
• NCCN/MEK Inhibitor GSK1120212 – Research Grant Opportunity (9/22/2011)
• Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline (8/31/2011)
• Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer (7/5/2011)
• NCCN Advances Oncology Imaging Research through the NCCN Specialized Imaging Research Consortium (5/27/2011)

For questions about NCCN or for interview information, please contact Carrie Capili 215.690.0238.

NCCN Oncology Research Program (ORP) News Archive

• National Comprehensive Cancer Network and Society of Nuclear Medicine Join to Advance Oncology Imaging Research (3/8/2011)
• NCCN Receives $2.1 Million in Oncology Research Funding from Pfizer (11/30/2010)
• NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline (7/27/2010)
• NCCN Survey Analyzes Clinical Trial Accrual at Academic Cancer Centers (6/4/2010)
• NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies (11/10/2009)
• NCCN Holds Oncology Research Best Practices Conference (9/14/2009)
• NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands into Developmental Therapies (4/29/2009)
• NCCN Receives $4 Million Oncology Research Grant from Wyeth (1/15/2009)
• Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN (12/1/2008)
• NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer (11/24/2008)
• NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies (10/7/2008)
• Is Cancer Community In Alignment About ‘Cure’ and ‘Costs’? NCCN Conference Panel Asks (3/7/2008)
• NCCN Receives Major Grant for Anti-Cancer Drug Study (11/15/2007)
• NCCN Receives $2 Million Grant from Pfizer (9/5/2006)
• NCCN and Roche Collaborate on Innovative Cancer Research (10/31/2005)
• Diane E. Paul, MS, RN, Joins National Comprehensive Cancer Network as Vice President, Clinical Trials Network (6/13/2005)
• Researchers Receive $1,886,237 in Funding from NCCN Clinical Trials Network (2/20/2003)
• The National Comprehensive Cancer Network Provides Physicians Easier Identification of Clinical Trials for Their Patients (11/5/2002)
• The National Comprehensive Cancer Network Launches Clinical Trials Network to Speed Drug Discovery (6/5/2002)
• Pharmacia Gives $3.15 Million Grant to NCCN to Advance Innovative Cancer Research Collaboration (1/1/2002)